Drug And Alcohol Screening Market Size, Share, Opportunities, And Trends By Sample Type, (Urine, Breath, Oral Fluid, Blood, Others), By End-User (Hospitals and Treatment Facilities, Law and Enforcement, Sporting Events, Others), And By Geography - Forecasts From 2025 To 2030

  • Published : May 2025
  • Report Code : KSI061612394
  • Pages : 141
excel pdf power-point

Drug And Alcohol Screening Market Size:

The Drug and Alcohol Screening Market is expected to grow from US$12.510 billion in 2025 to US$24.458 billion in 2030, at a CAGR of 14.35%.

Drug And Alcohol Screening Market Trends:

Drug and alcohol screening tests mainly analyze biological samples such as urine, blood, and hair to diagnose the presence of the drug. The rise in alcohol consumption, overuse of prescribed drugs, and the rise in usage of narcotics and illicit drugs are driving the global drug and alcohol screening market.

  • The enforcement of strict laws and regulations in various countries and financial support from the government are the key growth factors of the drug and alcohol screening market.

The rise in alcohol and drug abuse, growing knowledge, and awareness among developing countries, growing ageing population and competition among leading manufacturers in the drug and alcohol screening market for innovative products are the reason for the increasing demand for drug and alcohol screening. Technological advancement is expected to boost the market over the world for the forecast period. The ban on alcohol and drug consumption in some countries and accuracy issues in testing instruments are hindering the growth of the market in the coming years.

In terms of geography, the global drug and alcohol screening market has been classified into North America, South America, the Middle East, and Africa, Europe, and Asia-Pacific. Government policies toward drug usage are helping to grow more in North America. The Asia-Pacific region is going to be a new hub for exporting dug screening instruments.

Key players operating in the global drug and alcohol screening market are Abbott, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd and OraSure Technologies, among others. 

Drug And Alcohol Screening Market Scope:

Report Metric Details
Drug And Alcohol Screening Market Size in 2025 US$12.510 billion
Drug And Alcohol Screening Market Size in 2030 US$24.458 billion
Growth Rate CAGR of 14.35%
Study Period 2020 to 2030
Historical Data 2020 to 2023
Base Year 2024
Forecast Period 2025 – 2030
Forecast Unit (Value) USD Billion
Segmentation
  • Application
  • Products
  • Component
  • End-User Industry
  • Construction Type
  • Geography
Geographical Segmentation North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in the Drug And Alcohol Screening Market
  • Caterpillar
  • Komatsu
  • Volvo Construction Equipment
  • Hitachi Construction Equipment
  • Liebherr
Customization Scope Free report customization with purchase

 

Segmentation

The drug and alcohol screening market has been analyzed through the following segments:

  • By Sample Type
    • Urine
    • Breath
    • Oral Fluid
    • Blood
    • Others
  • By End-User
    • Hospitals and Treatment Facilities
    • Law and Enforcement
    • Sporting Events
    • Others
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • United Kingdom
      • Others
    • Middle East and Africa
      • Israel
      • South Africa
      • Others
    • Asia Pacific
      • China
      • Japan
      • South Korea
      • India
      • Others

Our Best-Performing Industry Reports:


Frequently Asked Questions (FAQs)

The drug and alcohol screening market is expected to reach a total market size of US$24.458 billion by 2030.

Drug And Alcohol Screening Market is valued at US$12.510 billion in 2025.

The drug and alcohol screening market is expected to grow at a CAGR of 14.35% during the forecast period.

The drug and alcohol screening market is driven by rising substance abuse, stringent regulations, workplace safety needs, and technological advancements.

The North American region is anticipated to hold a significant share of the drug and alcohol screening market.

1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
 
2. RESEARCH METHODOLOGY  
2.1. Research Design
2.2. Secondary Sources
 
3. EXECUTIVE SUMMARY
 
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
 
5. DRUG AND ALCOHOL SCREENING MARKET BY SAMPLE TYPE
5.1. Urine
5.2. Breath
5.3. Oral Fluid
5.4. Blood
5.5. Others
 
6. DRUG AND ALCOHOL SCREENING MARKET BY END-USER
6.1. Hospitals and Treatment Facilities
6.2. Law and Enforcement
6.3. Sporting Events
6.4. Others
 
7. DRUG AND ALCOHOL SCREENING MARKET BY GEOGRAPHY
7.1. North America
7.1.1. USA
7.1.2. Canada
7.1.3. Mexico
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. United Kingdom
7.3.2. Germany
7.3.3. France
7.3.4. Italy
7.3.5. Others
7.4. Middle East and Africa
7.4.1. UAE
7.4.2. Israel
7.4.3. Saudi Arabia
7.4.4. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan 
7.5.3. India
7.5.4. South Korea
7.5.5. Others
 
8. COMPETITIVE INTELLIGENCE
8.1. Market Positioning Matrix and Ranking
8.2. Recent Investments and Deals
8.3. Strategies of Key Players
 
9. COMPANY PROFILES
9.1. Abbott 
9.2. Premier Biotech, Inc.
9.3. Drägerwerk AG & Co. 
9.4. OraSure Technologies Inc.
9.5. Alfa Scientific Designs, Inc.
9.6. Lifeloc Technologies Inc.
9.7. Express Diagnostics Int’l
9.8. F. Hoffmann-La Roche Ltd 
9.9. Shimadzu Corporation
9.10. Siemens Healthineers
 

Abbott

Premier Biotech, Inc.

Drägerwerk AG & Co.

OraSure Technologies Inc.

Alfa Scientific Designs, Inc.

Lifeloc Technologies Inc.

Express Diagnostics Int’l

F. Hoffmann-La Roche Ltd

Shimadzu Corporation

Siemens Healthineers